- Home
- FGEN vs RPTX Comparison
FGEN vs RPTX Comparison
Compare FGEN & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- RPTX
- Stock Information
- Founded
- FGEN 1993
- RPTX 2016
- Country
- FGEN United States
- RPTX Canada
- Employees
- FGEN N/A
- RPTX N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- FGEN Health Care
- RPTX Health Care
- Exchange
- FGEN Nasdaq
- RPTX Nasdaq
- Market Cap
- FGEN 33.5M
- RPTX 38.3M
- IPO Year
- FGEN 2014
- RPTX 2020
- Fundamental
- Price
- FGEN $0.30
- RPTX $1.31
- Analyst Decision
- FGEN Strong Buy
- RPTX Strong Buy
- Analyst Count
- FGEN 1
- RPTX 3
- Target Price
- FGEN $10.00
- RPTX $4.50
- AVG Volume (30 Days)
- FGEN 594.8K
- RPTX 369.2K
- Earning Date
- FGEN 05-12-2025
- RPTX 05-13-2025
- Dividend Yield
- FGEN N/A
- RPTX N/A
- EPS Growth
- FGEN N/A
- RPTX N/A
- EPS
- FGEN N/A
- RPTX N/A
- Revenue
- FGEN $6,996,000.00
- RPTX $1,073,000.00
- Revenue This Year
- FGEN $232.81
- RPTX N/A
- Revenue Next Year
- FGEN $9.16
- RPTX N/A
- P/E Ratio
- FGEN N/A
- RPTX N/A
- Revenue Growth
- FGEN N/A
- RPTX N/A
- 52 Week Low
- FGEN $0.18
- RPTX $0.89
- 52 Week High
- FGEN $1.74
- RPTX $4.29
- Technical
- Relative Strength Index (RSI)
- FGEN 44.76
- RPTX 52.14
- Support Level
- FGEN $0.29
- RPTX $1.33
- Resistance Level
- FGEN $0.32
- RPTX $1.45
- Average True Range (ATR)
- FGEN 0.02
- RPTX 0.09
- MACD
- FGEN 0.00
- RPTX -0.01
- Stochastic Oscillator
- FGEN 26.25
- RPTX 28.57
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.